1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > OTC Pharmaceuticals: North America Industry Guide

OTC Pharmaceuticals: North America Industry Guide

  • October 2014
  • -
  • MarketLine
  • -
  • 100 pages

Introduction

The NAFTA OTC Pharmaceuticals industry guide provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The guide also contains descriptions of the leading companies including key financial metrics and analysis of competitive pressures within the market.

Features and benefits

* Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the NAFTA OTC pharmaceuticals
* Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the NAFTA OTC pharmaceuticals market
* Leading company profiles reveal details of key OTC pharmaceuticals players' NAFTA operations and financial performance
* Add weight to presentations and pitches by understanding the future growth prospects of the NAFTA OTC pharmaceuticals market with five year forecasts
* Compares data from the US, Canada and Mexico, alongside individual chapters on each country

Highlights

The North American Free Trade Agreement (NAFTA) is a trade agreement between the countries in North America: the US, Canada and Mexico. The OTC pharmaceuticals industry within the NAFTA countries had a total market value of $35,116.7 million in 2013.The Mexico was the fastest growing country, with a CAGR of 5% over the 2009-13 period.
Within the OTC pharmaceuticals industry, the US is the leading country among the NAFTA bloc, with market revenues of $29,272.9 million in 2013. This was followed by Canada and Mexico, with a value of $3,293.9 and $2,549.9 million, respectively.
The US is expected to lead the OTC pharmaceuticals industry in the NAFTA bloc, with a value of $31,913.3 million in 2018, followed by Canada and Mexico with expected values of $3,876.1 and $3,112.0 million, respectively.

Your key questions answered

* What was the size of the NAFTA OTC pharmaceuticals market by value in 2013?
* What will be the size of the NAFTA OTC pharmaceuticals market in 2018?
* What factors are affecting the strength of competition in the NAFTA OTC pharmaceuticals market?
* How has the market performed over the last five years?

Table Of Contents

OTC Pharmaceuticals: North America Industry Guide
INTRODUCTION
What is this report about?
Who is the target reader?
How to use this report
Definitions
NAFTA OTC PHARMACEUTICALS
Industry Outlook
OTC PHARMACEUTICALS IN CANADA
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators
OTC PHARMACEUTICALS IN MEXICO
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators
OTC PHARMACEUTICALS IN THE UNITED STATES
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Leading companies
Macroeconomic indicators
APPENDIX
Methodology

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
North America Vision Care Market Outlook to 2022

North America Vision Care Market Outlook to 2022

  • $ 5995
  • Industry report
  • December 2016
  • by GlobalData

North America Vision Care Market Outlook to 2022 Summary GlobalData’s new report, "North America Vision Care Market Outlook to 2022", provides key market data on the North America Vision Care market. ...

Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021

Animal Antibiotics and Antimicrobials Market by Product, Mode of Delivery, Animal - Global Forecast to 2021

  • $ 5650
  • Industry report
  • December 2016
  • by MarketsandMarkets

The global animal antibiotics and antimicrobials market is estimated to grow at a CAGR of 4.6% from 2016 to 2021, to reach USD 4.73 billion by 2021 from USD 3.77 billion in 2016. The growth of this market ...

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

U.S. Insomnia Market by Non-Pharmacological Therapy, Prescription Sleep Aids, Orexin Antagonist & OTC Treatment - Forecasts to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The U.S. insomnia market is projected to reach USD 4.24 billion by 2021 from USD 3.38 billion in 2016, growing at a CAGR of 4.6% from 2016 to 2021 In 2016, the cognitive behavioural therapy for insomnia ...

Otc Drugs Markets In China

January 2017 $ 4000

ref:plp2014

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.